Anuj Gaggar
Fortune : 54 960 $ au 30/06/2026
Fortune : 54 960 $ au 30/06/2026
Anuj Gaggar was the founder of Arrive Bio, founded in 2021, and served as Chief Executive Officer from 2021 to 2023.
Dr. Gaggar is currently Chief Medical Officer at Assembly Biosciences, Inc., starting in 2023.
Formerly, Dr. Gaggar was Vice President-Clinical Research at Gilead Sciences, Inc. from 2012 to 2021.
Education includes undergraduate studies at Stanford University and a doctorate from the University of Washington.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 2 000 ( 0,01 % ) | 54 960 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 08/11/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/04/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national